Menu
Logo

No new safety signals were observed in patients switched to INVEGA SUSTENNA® vs. oral antipsychotics

Header-trevicta
tolerability-profile.png
References
1. INVEGA® Ministry of Health approved leaflet, 18/3/2019.
2. Risperdal® Ministry of Health approved leaflet, 16/12/2019.
3. INVEGA SUSTENNA® Ministry of Health approved leaflet, 18/3/2019.
4. TREVICTA® Ministry of Health approved leaflet.19/5/2019.
5. Schreiner A, Aadamsoo K, Altamura AC, et al. Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia. Schizophr Res.2015;169(1-3):393-399.

CP-253618